EAACI - Search page

An accelerated up-dosing scheme using one strength for SCIT with a native HDM allergen extract proved safety and tolerability in Chinese children with allergic rhinitis with or without asthma

Omics technologies in allergy and asthma research: An EAACI position paper

Impact of Dupilumab Treatment on Clinical Remission in Patients with Uncontrolled, Moderate-to-Severe, Type 2 Asthma

The effects of the endocrine disruptors on asthma: bisphenolA and phthalates

Tackling severe asthma in real life

Targeted treatment in severe asthma

Treatment of severe asthma (update)

Bridging the Gap Between Type 2 Inflammation and Clinical Remission in Asthma

Exercise-induced Asthma: What's new?

Sanofi Regeneron - Clinical Remission as the Ultimate Goal in Asthma Management

The Inflammasome Inhibitor OLT1177 Improves Experimental Allergic Asthma in Mice

Therapeutic options for non T2 asthma

Dupilumab Treatment Induces Clinical Remission in Patients with Uncontrolled, Moderate-to-Severe, Type 2 Inflammatory Asthma

Trends İn Asthma Encounters and Pollution Before and After the COVID-19 Pandemic

Asthma exacerbation or something else?

The importance of assessing obstructive sleep apnoea (OSA) in adult asthma patients

Things to keep in mind in the differential diagnosis of severe asthma: ABPA and EGPA

Biomarkers for Predicting Type 2-high and Uncontrolled Asthma in Real-World Practice

TH2 inflammation is protective against serious outcomes among inner city asthmatics infected with SARS-CoV-2 Alpha Variant (SC2AV)

Effectiveness of allergen immunotherapy (AIT) under real life conditions from a German retrospective cohort study in children, adolescents and adults with house dust mite (HDM) induced allergic rhinitis (AR) and asthma (AA)

The next era in severe asthma management

GSK Medical - IL-5 inhibition in CRSwNP and severe asthma: impact beyond the eosinophil

The role of TSLP in driving severe asthma

Management of severe asthma in adolescents

Effect of Omalizumab on Asthma Outcomes in Adolescents/Adults with Asthma and Food Allergy

Effect of Omalizumab on Asthma Outcomes in Pediatric Patients with Asthma and Food Allergy

Asthma pheno-endotyping for experts Part 1

Asthma pheno-endotyping for experts Part 2

Microbial triggers of asthma exacerbations

Assessment of systemic inflammation and asthma control in asthma patients with elevated BMI

AstraZeneca - Targeting eosinophils in severe asthma: real-world data and clinical remission

Antibiotic prescription practices for acute asthma exacerbations: results of an EAACI survey

Asthma endotypes: static or fluid entities?

Airway Epithelial Antiviral Immunity is Enhanced by Allergen Immunotherapy in Allergic Asthma

TMT-Based Quantitative Proteomic Analysis Reveals Downregulation of ITGAL and Syk by the Effects of Cycloastragenol in OVA-Induced Asthmatic Mice

Efficacy of Dupilumab in Patients With Asthma Stratified by a Minimally Important Fractional Exhaled Nitric Oxide Reduction at Week 2 of Treatment

The development in confirmed asthma and allergy diagnoses at Allergy Center AUH through 10 years

The central role of patients in severe asthma

Phenotypic and Treatment Efficacy Analysis of Mold-Sensitive Asthmatic Patients; SAFS, ABPA, ABPM

Long-term Exposure to PM2.5, PM10 and Lung Function in Adult Asthma Based on Land-use Regression

Comorbid asthma and CRSwNP: the patient impact

Biomarkers expression, treatment and disease burden in a cohort of Italian patients affected by severe asthma: a sub analysis of the ISAR EVEREST study

Burden of illness in a cohort of Italian patients eligible for biologics for asthma but not treated: a sub analysis of the real-world ISAR EVEREST study

Management of pediatric asthma – What is new?

AstraZeneca - Transforming asthma care for a broad population of severe uncontrolled asthma patients

Assessing Disease Activity to Better Define On Treatment Clinical Remission in Pediatric Severe Asthma

Real-world outcomes of patients with severe asthma treated with mepolizumab by baseline inhaled corticosteroid dose: post hoc analysis of REALITI-A at 2 years

Efficacy and Safety of Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in Subjects Aged 1-3 Years With and Without Concomitant Asthma in the EPITOPE Study

Obese and Non-obese Patients With Severe Asthma: Comparison of Omalizumab-Mepolizumab Treatment Outcomes

Anaphylaxis due to anti-asthmatic biologics: analysis of VigiBase®, the WHO pharmacovigilance database

The role of exhaled biomarkers in pediatric asthma

Self-reported and physician diagnosed asthma amongst allergic rhinitis patients enrolling in an ILIT trial

Antibiotic stewardship in asthma exacerbations: outcomes and recommendations of an EAACI task force survey

Treatment on chronic rhinitis and impact on asthma

Asthma exacerbations: towards personalised medicine

CSN5 is a circulating marker for asthma exacerbation

Analysis of differentially expressed microRNAs and their target genes in lung tissue from asthmatic individuals

Exploring the Interaction between Genetic Risk Score and Exercises on Asthma by a Genome-wide Association Study

The polybacterial mucosal vaccine MV130 impairs airway inflammation in a HDM-induced eosinophilic asthma model

Microbiota, children wheeze and adult asthma severity

How can we address the excess reliever use in asthma?

Blood sphingolipid profiling of obese and lean asthmatic children from Middle East and North Africa (MENA) region

The role of p300 in the pathogenesis of allergic asthma

Extreme air conditions i.e.Thunderstorms etc and asthma

Allergic bronchopulmonary aspergillosis revealig asthma

Industry Symposium - AstraZeneca Italy Symposium - Tezepelumab the firstand only anti- TSLP biologic in severe asthma

Severe uncontrolled allergic asthmatic patients display a specific miRNA profile associated to asthma and inflammation

Impact of sublingual immunotherapy on asthma onset in patients with allergic rhinitis: results from the EfficAPSI study

Asthma Outcomes with Benralizumab in Biologic-Naïve and Biologic-Experienced Patients with Severe Eosinophilic Asthma (SEA) in an Integrated Analysis of the Real-World XALOC-1 Study

Evaluation of the TGF-beta isoforms in asthmatic patients

Understanding the effect of clinical baseline characteristics on SABA reliever use in patients with moderate-severe asthma

High dose ICS in children with recurrent wheeze or asthma.

Longitudinal trajectories of childhood asthma phenotypes and allergic comorbidities in Korean childhood Asthma Study (KAS)

Characterization and evaluation of the impact of comorbidities in patients with uncontrolled asthma and SARS-COV-2 infection

Real-world clusters of severe asthma from the Italian Registry on Severe Asthma (IRSA): a longitudinal Latent Class Analysis

Measuring adherence to inhaled asthma controller medication

The Effect of an Educational Program for Children with Asthma on Airway Inflammation: Before and During the COVID-19 pandemic

ORBE II: Analysis of atopic vs non-atopic patients with severe asthma treated with benralizumab in clinical practice in Spain

Evaluation Of The Relationship Between Asthma Severity And Cardiac Functions By Speckle Tracking Method In Pediatric Patients

The 4E Non-Pharmacological Factors (Environment, Eating, Exercise, Emotion) Effects on Asthma Control Among Asthmatic Patients

Nuclear factor of activated T cells 1 (NFATc1) in CD11c+ dendritic cells drives eosinophilic inflammation in asthmatic patients

Industry Symposium - Chiesi Italy Symposium - New opportunity in themanagement and treatment of asthma: Extrafine Triple Therapy

Association between Asthma and Cardiovascular diseases: A longitudinal follow-up studies using a national health screening cohort

Efficacy of Dupilumab 200 mg Every 2 Weeks in Children with Moderate-to-Severe Asthma: A Post Hoc Analysis of VOYAGE and EXCURSION

The genetic variability of treatment response in severe asthma

Beyond inflammation in severe asthma: the central role of TSLP

Clinical and Biomarkers characteristics of Severe Asthma Patients who initiated Biologic Therapy: a Colombian single center experience

Serum testosterone and obese asthma phenotypes: the story of men

Dual Monoclonal Antibody Therapy In A Patient With Uncontrolled Severe Chronic Rhinosinusitis With Nasal Polyps and Eosinophilic Asthma

Evaluation of Omalizumab and Mepolizumab Treatment Efficacy in Severe Asthmatics Associated with NSAID-Exacerbated Airway Disease (N-ERD)

Tezepelumab: the new promise to challenge severe asthma complexity

Impact of childhood diseases and familial asthma history on adult asthma characteristics: results from Turkish Adult Asthma Registry (TAAR)

Asthma due to irritant agents: does it exhibit a distinct endotype?

Effects of Climatotherapy on Quality of Life in Children with Asthma

The impact of mepolizumab self-administration on real-world outcomes in patients with severe asthma: post hoc analysis of REALITI-A at 2 years

The impact of asthma on Post COVID Condition (PCC) and COVID symptoms

Impact of sublingual immunotherapy on asthma worsening in patients with allergic rhinitis and associated asthma: results from the EfficAPSI study

ACAAI members’ preferred step 1-3 asthma maintenance and reliever therapy and practice hurdles, mainly related to incomplete insurance coverage

Impact of COVID-19 Pandemic on Childhood Asthma and Wheezing Disorders

The Dietary Inflammatory Index is related to asthma and lung function: Analysis of Korea National Health and Nutrition Examination Survey (KNHANES)

Therapeutic implications of the comorbidities of severe allergic asthma

The non-interventional real-life study with a combination of beclomethasone dipropionate and formoterol in HFA or DPI 100/6µg inhalers as maintenance and reliever therapy in patients with moderate persistent uncontrolled asthma

PAAI - Interactive online self-learning programme for patients with asthma: a patient-and carer-centred approach on the most relevant topics to address

House dust mite sublingual immunotherapy formulation for allergic asthma: A systematic review and meta-analysis of randomised and nonrandomised studies

The T2 spectrum of asthma patients in an expert clinic in the Netherlands

Clinical characterization of severe asthma in young adults and patients with NSAID-exacerbated respiratory disease. Results of the BIOBADALER consortium

The potential of anti-infectives and immunomodulators in pediatric asthma

Long-term, real-world effectiveness of allergy immunotherapy in children with allergic rhinitis and pre-existing asthma. Subgroup analysis of the REACT-study

Prevalence of self-reported asthma and atopic comorbidities in an adult general population sample from Germany: Results from the Study of Health in Pomerania

Hypersensitivity reactions to biologic agents in patients with severe asthma

Case 3 – Flora: Anaphylaxis – Connection between asthma and food allergy

Evaluating treatment responses of dupilumab versus omalizumab in severe chronic rhinosinusitis with nasal polyps and comorbid asthma patients: the EVEREST trial

Dupilumab Improves Lung Function and Reduces Exacerbation in Children (6 to 11 Years) With Moderate-to-Severe Asthma and High Blood Eosinophil Count at Baseline

Metabolomic analysis of bronchoalveolar lavages from severe asthmatic children

Prevalence and risk factors for asthma among adults in an East African country

Examining the Latest Evidence of Clinical Remission in Asthma With Biologic Use

Occupational dust mite asthma in a thrift shop company : A case report of 9 cases

Biomarkers to predict long-term outcomes in childhood asthma: A systematic review

Hesperidin ameliorates asthma by regulating the barrier function of epithelial cells

Clinical Remission in Patients with Severe Eosinophilic Asthma with Benralizumab According to Body Mass Index Status in an Integrated Analysis of the Real-World XALOC-1 Study

Reliability of the Asthma Quality of Life Questionnaire in the Republic of Kazakhstan

ILC2, MSF, PTX3 AND GAL3 regulation in patients with severe eosinophilic asthma with or without chronic rhinosinusitis with nasal polyps treated with mepolizumab: study protocol

Anaphylaxis and occupational asthma allergic caused by carmine ( E-120): a case report

Treating to remission: is it achievable in severe eosinophilic asthma in the real world?

The interaction effect between genetic risk score and obesity on asthma and lung function

Farm-dust mediated asthma protection in childhood: Dendritic cell-mediated T cell priming

Transcriptomic studies of response to biologicals in severe asthma; what do they suggest?

Oral corticosteroid sparing effect of sublingual liquid immunotherapy in patients with allergic rhinitis with or without associated asthma in real practice: results from the EfficAPSI study

A study on the association of asthma onset in infants and toddlers with croup using big data

Specific IgG4 and sIgE Ab to mite and cat component allergens and asthma: sIgG4 responses have a controlling effect in relation to Der p 1 and Fel d 1, which have quantitatively higher exposure

Towards standardisation of clinical outcomes used in allergen immunotherapy in allergic asthma

A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes

A prospective study of cognitive and olfactory function in patients with moderate to severe asthma

Targeting type 2 inflammation: Use of Dupilumab in Chronic Rhinosinusitis with Nasal Polyps and the effect on co-existing asthma. The experience of the Allergy Unit ‘’D. Kalogeromitros’ in Greece

Single house dust mite allergens as potential biomarkers for allergic asthma and atopic dermatitis

Significant bronchodilator response in oscillometry and spirometry in relation to asthma and wheeze

The relationship between asthma and mental health conditions in national samples of Canadian children

Trends in asthma among children in Denmark, Finland, Norway and Sweden in nationwide register-based cohorts

The impact of anti-IL5 therapies in allergic patients with severe asthma, with and without fungal sensitization

Global, regional, and national trends in incidence of asthma: findings from the Global Burden of Disease Study 2019

The roles of FeNO in predicting asthma and sensitization to common aeroallergens in patients with allergic rhinitis

Study of the effectiveness of the Connect 360 Program for the control of our asthmatic Benralizumab treated patients

Analysis of the gene expression of four potential asthma triggers in peripheral and lung samples of asthmatic patients

Response to treatment with dupilumab in patients with asthma and/or chronic rhinosinusitis and nasal polyposis (CRScNP)

A survey of the parental experience of colour-coded written asthma management plan for home-based parent-led asthma care

Severe bronchial hyperresponsiveness along with house dust mite allergy indicates persistence of asthma in young children

Cat exposure, IgE and IgG4 antibodies to cat allergens, and asthma in a birth cohort; The modified Th2 response revisited

Molecular sensitisation profile to dogs in residents of Latvia and its connection with asthma and the course of allergic rhinitis

Impact of single inhaler triple therapy in asthmatic patients lung function: experience of an Allergy and Clinical Immunology Unit

Withdrawal of inhaled corticosteroids in severe T2-low obesity-related asthma: results from an open-label randomized crossover trial

The effect of allergen-specific immunotherapy on the quality of life of school-age children with asthma and sensitization to cat allergens

How epithelial cytokines affect immune cell function and the clinical consequences in allergy, severe asthma and upper airways disease

Mepolizumab therapy decreases epithelial-derived cytokine concentrations in exhaled breath condensates from patients with severe eosinophilic asthma

Dysregulation of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) leads to lung fibrosis in house dust mite-induced experimental asthma

The expression of CYSLTR2 is reduced after treatment with benralizumab in severe asthma patients with and without nasal polyposis: a prospective study

The sensitization profile in monosensitized and polysensitized children with isolated asthma, isolated rhinitis and combined rhinitis and asthma syndrome

Phenotypical distribution according to Asthma age of onset in patients evaluated for biologic therapy prescription in a reference center at high altitude

Identification of two miRNA clusters in plasma-derived extracellular vesicles specifically linked to pathomechanims of obesity-associated low type-2 asthma

Hypersensitivity to dog allergens: dependence of the severity of symptoms of allergic rhinitis and/or asthma on sensitization to allergenic proteins of the dog

Combined dietary intervention with scFOS/lcFOS and Bifidobacterium breve limits airway hyperresponsiveness in a mouse model for house dust mite allergic asthma

CD62Llow eosinophils proportion correlates with clinical parameters of asthma and chronic rhinosinusitis and in vivo/in vitro effect of Mepolizumab on eosinophil subpopulations

The impact of anti-IL5/5R therapies on reducing exacerbations and systemic corticosteroids in severe asthma: a comparison between allergic versus non-allergic asthmatic patients

GSK - Redefining ambition: Getting to grips with Clinical Remission in IL-5-driven severe asthma and stepping up expectations for patients with chronic rhinosinusitis with nasal polyps

Viral etiologies of preschool wheezing and how do they relate to different phenotypes of preschool asthma

Biomarker-guided approach for management of preschool asthma

Early immune development – relevance for allergic diseases and asthma

New Epidemiologic Factors Related to allergy and asthma

Updates in the association between air pollution, allergy, and asthma.

Novel analytical tools to endotype asthma and allergic diseases

Can carpets be asthma & allergy friendly?

Polymorphism of Тumor necrosis factor-alpha gene in children with bronchial asthma

Prevalence of bronchial asthma in children and adolescents in Poland

Characteristic analysis of asthmatic airflow using computed tomography images incorporating computational fluid dynamics

Validation of cluster analysis of sputum cytokine profiles in asthmatic patients reveals underlying molecular pathways and impact of environmental triggers

Farm-dust mediated upregulation of activated B-cells in asthmatic and healthy children

Effect of inhalation formulation on bronchial obstruction in teen-aged asthmatics

Composition, structure, function, and interactions of the nasal bacteriomes in allergic rhinitis patients with or without comorbid asthma

Biologicals in asthma - from clinical trials to real life

Dupilumab is effective in children (6–11 years) with moderate-to-severe asthma and high eosinophils at baseline

Evaluation of asthma control and quality of life in elderly patients under biological monoclonal antibody

Case 1 – Jordi: United airways – connection between rhinitis and asthma

Redefining ambition: Looking to the future of severe asthma management

Endotyping occupational asthma: progress and challenges in current practice

Work-related asthma, from phenotypes to endotypes: when did we start and where are we?

Occupational asthma endotyping: the past and the future.

Environmental influences on allergy and asthma development – what is detrimental?

Green spaces and allergy and asthma development.

Novel therapeutic approaches in severe asthma

Biologicals in asthma - from clinical trials to real life

Unraveling new biomarkers for asthma treatment monitoring with biologics using metabolomics

Lung function in asthmatic old patient under antibody monoclonal therapy: the experience from a Portuguese tertiary hospital

Flash talks on asthma treatment

Biologics targeting eosinophils in severe asthma: what is the real-world evidence to date?

Breathomics in asthma diagnosis

Utility if breathomics in the diagnosis asthma

Prostaglandin, fatty acid, and glycerophospholipid measurements in breath samples can identify individuals with asthma

Effectiveness and safety of house dust mite-polymerized extract in pediatric patients with allergic rhinitis and/or asthma: a prospective cohort study

Features of sensitization and genetic factors in the development of asthma in the Kazakh population

Prevalence of asthma and asthma-related risk factors in pre-term infants based on 2002–2018 Korea national health insurance claims data

Preventive counseling on the risk factors of the population with asthma or chronic obstructive pulmonary disease

Immunodeficiency accompanying severe asthma and chronic urticaria

Differences in baselinecharacteristics of bionaïve and switchers to anti-IL4/IL13 treatment in servere asthma patients

Bronchodilator response and methacholine testing in young children with suspected asthma: which test is more helpful in clinical practice?

Chronic eosinophilic pneumonia and asthma: a diagnostic and management challenge

Overlap of severe asthma and alpha-1 antitrypsin deficiency

Difficult-to-treat asthma: importance of additional investigation in pediatric patients

Interleukin 1-beta correlates with cough reflex sensitivity in children with asthma

Guinea pig domestic exposure could be associated to severe forms of allergic asthma and allergic rhinitis

Cannabinoid receptor 2 as a regulator of inflammation induced by oleoylethanolamide in eosinophilic asthma

Flash talks on asthma

Eosinophilic component is ubiquitous among allergic bronchopulmonary aspergillosis with atopic, non-atopic, and sans asthma – factor analysis –

Evaluation if probiotics may ameliorate ovalbumin-induced atopic dermatitis and asthma in mice

Reduction of systemic corticosteroid courses in severe asthmatic patients receiving a biological treatment

Nasal interferon-swap in wheezing and asthmatic children carrying 17q21 risk allel

Respiratory allergic manifestations (asthma and rhinitis) in children followed for food allergy

Biomarkers can guide the choice of a biological in severe asthma

Filling the knowledge gaps in asthma: Real-world evidence data

Obesity, inflammation and severe asthma

Rhinovirus-induced epithelial RIG-I inflammasome activation suppresses antiviral immunity and promotes inflammatory responses in virus-induced asthma exacerbations and COVID-19

Beyond eosinophils: the broader role of IL-5 in severe asthma

Clinical implications of mucus plugging and mucus hypersecretion in severe asthma and the potential role of epithelial cytokines

Lactobacillus paracasei-derived extracellular vesicles alleviate neutrophilic asthma

Epigenetic regulation of early and late asthmatic reactions in allergic asthma

Diagnostic accuracy of cereal-specific IgE in flour-induced occupational asthma

Could specific IgE sensitization patterns to dog molecular allergens determine asthma risk?

Biologicals in asthma and atopic eczema in elderly: age-specific considerations

Distinct activation of major nasal phenotypes in wheezing and asthmatic children

Differential gene expression in cord blood associated with childhood asthma diagnosis later in life

Effects of allergic comorbidities and aeroallergen sensitization on childhood asthma severity

Der p 2, but not Blomia tropicalis specific-allergens, is a common sensitizer in children with asthma living in Bogotá-Colombia, a high-altitude tropical city

Exhaled nitric oxide in the management of asthma

Biologicals in asthma

Patient-centred composite index for assessment of response to biological therapy for paediatric severe asthma

Predicting factors for response to mepolizumab after 3 years of follow up in patients with severe eosinophilic asthma

Complete vs. non-complete responders to benralizuman, mepolizumab and omalizumab in severe asthma patients: a long-term retrospective analysis

Omalizumab for severe food allergy in a large Italian cohort of asthmatic children

Real-life efficacy of biologicals in patients with severe asthma phenotype overlap. Experiences from a tertiary pulmonary centre

Biological treatment of severe asthma during pregnancy

Experience of omalizumab treatment of severe bronchial asthma combined with severe vernal keratoconjunctivitis

Critical window of microbial colonization for shaping innate immunity and its relation to asthma risk

Regular use of nasal powder methyl-cellulose in asthma patients with associated rhinitis reduces asthma exacerbations

Dupilumab in improving control of severe asthma in real life. Report of two cases

Biological treatment in severe asthma phenotype overlap- insights from a tertiary pulmonary centre

Interleukin 33 and asthma

Immunological phenotyping of asthma exacerbations

Flash talks on asthma II

Learn the basics of severe asthma

United airways in severe asthma

Non-allergic rhinitis and asthma

Genome-wide association studies in severe asthma

Epigenetics in severe asthma

Immunodeficiencies and airway infections in severe asthma exacerbations

Development and protection in pediatric severe asthma

Prevention on pediatric severe asthma

Resolution: beyond asthma control

Is there a role for allergen immunotherapy in severe asthma?

Biomarkers for allergen immunotherapy in asthma

Prevalence and phenotypes of pediatric asthma

Diagnosis of pediatric asthma

Novel targets in severe asthma

Neurogenic inflamation in asthma

Predictive markers of asthma remission

Dual biologics therapy in a patient with severe asthma and chronic urticaria

Discrepancy between lung function and symptoms in a severe asthma case

Inflammatory pathways in severe asthma

Innate immunity in severe asthma

Early events in infancy and the development of asthma, allergy and tolerance

Doctor, does my baby has asthma?

Personalized application of Biologics in pediatric allergy and asthma

Root and branch of childhood asthma management

Bronchiolitis and future risks for childhood asthma

Biomarker-guided approach for treatment of preschool asthma

Optimising asthma management in children

Childhood asthma: pathogenesis and phenotypes

Biological for asthma: who, which one and how to assess response?

From preschool wheezing to asthma: determinants

Welcome

What are you looking for?

Website

Knowledge Hub